GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Todos Medical TOMDF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

About Todos Medical

Its shares trade under the ticker TOMDF. It has been listed since 21 February 2017. In the fiscal year to 31 December 2022, it reported revenue of $7.7m and a net loss of $25.0m. At that date it held total assets of $15.3m and shareholders' equity of −$35.5m.

Todos Medical Ltd. engages in the development of patient-friendly blood tests for the screening of cancers. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
21 Feb 2017
Employees
4

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Established reputation in the medical industry, known for providing reliable and high-quality products.
  • Strong research and development capabilities, leading to innovative and advanced medical solutions.
  • Wide range of product offerings that cater to various medical needs.

Weaknesses

  • Relatively small market share compared to larger competitors in the industry.
  • Limited geographical presence, with a focus on specific regions only.
  • Dependence on third-party suppliers for certain components, resulting in potential supply chain disruptions.

Opportunities

  • Growing demand for advanced medical technologies and diagnostics, presenting opportunities for market expansion.
  • Increasing global healthcare expenditure, which can lead to higher adoption of medical products.
  • Collaborations and partnerships with other healthcare companies to enhance market reach and product offerings.

Threats

  • Intense competition from larger and more established companies within the medical industry.
  • Regulatory challenges and compliance requirements that might affect product development and distribution.
  • Economic downturns and recessions, which could reduce overall healthcare spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.